We are live on ! Find out more
WC

Woodstock Corp Portfolio holdings

AUM $1.2B
1-Year Est. Return 26.37%
This Fund
S&P 500
This Quarter Est. Return
+2.54%
1 Year Est. Return
+26.37%
3 Year Est. Return
+96.13%
5 Year Est. Return
+140.78%
10 Year Est. Return
+511.51%
AUM
$493M
AUM Growth
+$4.6M
Cap. Flow
-$3M
Cap. Flow %
-0.61%
Top 10 Hldgs %
24.56%
Holding
163
New
6
Increased
37
Reduced
97
Closed
2

Sector Composition

Rank Sector Weight
1 Healthcare 23.33%
2 Technology 15.91%
3 Industrials 12.48%
4 Consumer Staples 9.69%
5 Communication Services 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
126
Gilead Sciences
GILD
$162B
$353K 0.07%
4,932
-875
-15% -$65K
BABA icon
127
Alibaba
BABA
$309B
$346K 0.07%
3,936
-805
-17% -$77.5K
DHR icon
128
Danaher
DHR
$140B
$346K 0.07%
5,020
NUAN
129
DELISTED
Nuance Communications, Inc.
NUAN
$330K 0.07%
25,557
-5,198
-17% -$66.9K
AKAM icon
130
Akamai
AKAM
$17.8B
$328K 0.07%
4,919
-1,008
-17% -$64.2K
PAYX icon
131
Paychex
PAYX
$41.4B
$324K 0.07%
5,325
VRTX icon
132
Vertex Pharmaceuticals
VRTX
$122B
$318K 0.06%
4,319
-854
-17% -$69.5K
JCI icon
133
Johnson Controls International
JCI
$93.5B
$293K 0.06%
7,119
DELL icon
134
Dell
DELL
$302B
$292K 0.06%
18,903
-8,060
-30% -$116K
IRM icon
135
Iron Mountain
IRM
$36.7B
$288K 0.06%
8,862
SIOX
136
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$281K 0.06%
2,823
+455
+19% +$47.9K
LLY icon
137
Eli Lilly
LLY
$1.02T
$279K 0.06%
3,800
DOV icon
138
Dover
DOV
$28.5B
$277K 0.06%
4,581
KERX
139
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$276K 0.06%
47,017
-9,576
-17% -$52.3K
FCX icon
140
Freeport-McMoran
FCX
$99.4B
$245K 0.05%
18,551
-3,612
-16% -$46.2K
SPY icon
141
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$236K 0.05%
1,057
+76
+8% +$16.6K
RP
142
DELISTED
RealPage, Inc.
RP
$236K 0.05%
7,882
-1,617
-17% -$45.1K
PETX
143
DELISTED
Aratana Therapeutics, Inc.
PETX
$235K 0.05%
32,680
-6,664
-17% -$53.9K
IJR icon
144
iShares Core S&P Small-Cap ETF
IJR
$113B
$223K 0.05%
3,244
GBCI icon
145
Glacier Bancorp
GBCI
$6.57B
$208K 0.04%
+5,750
New +$185K
ATW
146
DELISTED
Atwood Oceanics
ATW
$202K 0.04%
15,365
-3,136
-17% -$30.8K
CI icon
147
Cigna
CI
$71.3B
$200K 0.04%
+1,500
New +$196K
TTOO
148
DELISTED
T2 Biosystems, Inc
TTOO
$163K 0.03%
6
-1
-14% -$30.8K
EPM icon
149
Evolution Petroleum
EPM
$125M
$149K 0.03%
14,950
-3,052
-17% -$25.6K
DNR
150
DELISTED
Denbury Resources, Inc.
DNR
$142K 0.03%
38,654
-7,854
-17% -$25.3K

Similar funds

Woodstock Corp's Q4 2016 Portfolio in Review

As of Q4 2016, Woodstock Corp held 163 positions worth $493M, up 0.94% from $489M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q4 2016: portfolio turnover was 4.9%. Woodstock Corp opened 6 new positions and exited 2, leaving the 163-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

  • Woodstock Corp's largest Q4 2016 buy was GW Pharmaceuticals Plc American Depositary Shares: 5,934 shares worth $663K.
  • Woodstock Corp added most to Hanesbrands in Q4 2016, an estimated $1.5M increase.
  • Woodstock Corp's biggest Q4 2016 reduction was bluebird bio, cutting an estimated $644K.
  • Woodstock Corp fully exited Vanguard FTSE All-World ex-US ETF in Q4 2016, selling an estimated $202K.
  • Woodstock Corp's ten largest holdings make up 25% of its $493M portfolio in Q4 2016.
  • Woodstock Corp opened 6 new positions and closed 2 in Q4 2016.
  • Woodstock Corp's portfolio value rose 0.94% quarter-over-quarter to $493M.

Based on Woodstock Corp's 13F filing for Q4 2016, filed 6 Jan 2017.